Anthem (ANTM) was upgraded to buy from neutral at Goldman Sachs. $168 price target. The stock is trading at a 25% discount to its peers and should be able to boost prices with Express Scripts (ESRX) , Goldman said.
Comerica (CMA) was upgraded to outperform from market perform at FBR Capital Markets. $48 price target. Sentiment is low, but the company is trading at a 12% discount to tangible book value, FBR said.
Fortinet (FTNT) was downgraded to neutral from overweight at Piper Jaffray. $30 price target. Waning demand will likely pressure margins, Piper said.
Genesco (GCO) was upgraded to overweight from neutral at Piper Jaffray. $65 price target. The company can expand margins and repurchase more stock, Piper said.
Gilead Sciences (GILD) was initiated with an outperform rating at Credit Suisse. $125 price target. The company is attractively valued at 7x earnings, Credit Suisse said.
Investment Technology (ITG) was upgraded to overweight from neutral at JPMorgan. $20 price target. The company is trading at 2x cash, and business trends are improving, JPMorgan said.
LifePoint Hospitals (LPNT) was downgraded to neutral from buy at Goldman Sachs. The valuation is less attractive, based on an $81 price target, Goldman said.